Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI)
€ 88.2 0.4 (0.46%) Market Cap: 4.51 Bil Enterprise Value: 4.55 Bil PE Ratio: 33.53 PB Ratio: 8.48 GF Score: 88/100

Laboratorios Farmaceuticos ROVI SA Capital Market Day 2022 Transcript

Nov 23, 2022 / 09:00AM GMT
Release Date Price: €36.76 (-10.17%)
Marta Campos MartÃ;nez;Juan Lopez;Belmonte Encina
Laboratorios

­ -

Capital Markets Day. Let me introduce myself, my name is Marta Campos, and I'm the Head of Investor Relations at Rovi. This morning, Mr. Juan Lopez-Belmonte, our Chairman and CEO, will be updating the key points of Rovi's strategy and provided an overview of the company's current status.

Afterwards, Mr. Ibón Gutierro, our R&D Manager, will talk about the R&D strategy based on our ISM platform. And finally, Mr. Javier Lopez-Belmonte, our Deputy Chairman and CFO, will give you an update on Rovi's financial situation.

At the end of the presentation, there will be a 30-minute question-and-answer session. Don't hesitate to send us your questions clicking on the bottom of your screen and people attending the presentation in person just have to raise their hand and someone will come up with a microphone. So you can ask directly. Thank you very much for being here today.

And let's now start with the presentation. I give Mr. Juan Lopez-Belmonte the floor.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot